Publications by authors named "Edward L Morgan"

Claim this Profile
A
A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killing.
Courtney K Cavaco, Kathryn A Patras, Jaime E Zlamal, Marilyn L Thoman, Edward L Morgan

Antimicrob Agents Chemother· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
Chiung-Yu Hung, Brady J Hurtgen, Michael Bellecourt, Sam D Sanderson, Edward L Morgan

Vaccine· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide.
Tamsin R Sheen, Courtney K Cavaco, Celia M Ebrahimi, Marilyn L Thoman, Sam D Sanderson, Edward L Morgan

Vaccine· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel adjuvant for vaccine development in the aged.
Edward L Morgan, Marilyn L Thoman, Sam D Sanderson, Joy A Phillips

Vaccine· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine design.
Edward L Morgan, Brandon N Morgan, Elisabeth A Stein, Elizabeth L Vitrs, Marilyn L Thoman

Vaccine· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-step conjugation of bioactive peptides to proteins via a self-contained succinimidyl bis-arylhydrazone.
Joy A Phillips, Edward L Morgan, Yuxiang Dong, Garry T Cole, Cody McMahan

Bioconjug Chem· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis